Boxer Capital as of March 31, 2019
Portfolio Holdings for Boxer Capital
Boxer Capital holds 23 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mirati Therapeutics | 14.5 | $126M | 1.7M | 73.30 | |
| Beigene (ONC) | 13.7 | $119M | 900k | 132.00 | |
| Immunomedics | 9.1 | $79M | 4.1M | 19.21 | |
| Odonate Therapeutics Ord | 7.6 | $66M | 3.0M | 22.11 | |
| Uniqure Nv (QURE) | 6.5 | $57M | 950k | 59.65 | |
| Biogen Idec (BIIB) | 5.5 | $47M | 200k | 236.38 | |
| Gossamer Bio (GOSS) | 4.7 | $41M | 1.9M | 21.67 | |
| Esperion Therapeutics (ESPR) | 4.5 | $39M | 975k | 40.15 | |
| Wave Life Sciences (WVE) | 4.5 | $39M | 1.0M | 38.85 | |
| Ptc Therapeutics I (PTCT) | 4.3 | $38M | 1.0M | 37.64 | |
| Dbv Technologies S A | 3.7 | $32M | 4.2M | 7.71 | |
| Allakos | 3.7 | $32M | 799k | 40.50 | |
| Solid Biosciences | 3.7 | $32M | 3.5M | 9.20 | |
| Rocket Pharmaceuticals (RCKT) | 3.0 | $26M | 1.5M | 17.54 | |
| Medicines Company | 1.9 | $17M | 600k | 27.95 | |
| Cymabay Therapeutics | 1.9 | $17M | 1.3M | 13.28 | |
| Kura Oncology (KURA) | 1.6 | $14M | 845k | 16.59 | |
| Global Blood Therapeutics In | 1.5 | $13M | 250k | 52.93 | |
| Matinas Biopharma Holdings, In | 1.3 | $11M | 10M | 1.09 | |
| Mei Pharma | 1.0 | $8.9M | 2.9M | 3.07 | |
| Kalvista Pharmaceuticals (KALV) | 0.7 | $5.7M | 200k | 28.62 | |
| Kiniksa Pharmaceuticals | 0.6 | $5.2M | 291k | 18.06 | |
| Novus Therapeutics | 0.1 | $1.3M | 324k | 4.02 |
